One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.


Specialized clinical information about coronavirus COVID-19

The situation is rapidly evolving, and information is being constantly updated. Last updated

View FAQs about COVID-19 and people living with HIV

View FAQs
Coronavirus Innovation Map
Coronavirus disease (COVID-19): HIV and antiretrovirals
Rights in the time of COVID-19. Lessons from HIV for an effective, community-led response.
What People Living with HIV Need to Know about HIV and COVID-19
EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH)
Special CROI-2020 session on COVID-19
SARS-CoV-2 /COVID-19 - Antiviral and immunomodulatory treatment considerations
Interim clinical guidance for patients suspected of/confirmed with COVID-19 in Belgium
Inpatient guidance for treatment of COVID-19 in adults and children (University of Michigan, USA)
Руководство по лечению и поддерживающей терапии пациентов с коронавирусной инфекцией COVID-19 (Италия, Ломбардия)
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) (Released by National Health Commission & State Administration of Traditional Chinese Medicine)
“Solidarity” clinical trial for COVID-19 treatments
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time
Lopinavir-ritonavir is not an effective treatment for patients hospitalised with COVID-19 (Recovery)
A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) in Nature Reviews
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
NIH Final report confirms remdesivir benefits for COVID-19
WHO Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Remdesivir for the Treatment of Covid-19 — Final Report
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Novel COVID-19 Vaccine Candidate hAd5
Use of adenovirus type-5 vectored vaccines: a cautionary tale
“Sputnik V” the first registered COVID-9 vaccine
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
BCG vaccination to Reduce the impact of COVID-19 in Australian healthcare workers following Coronavirus Exposure (BRACE) Trial
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection (in USA)
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Statement from the Chief Investigators: no clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)
A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection
EATG (European Aids Treatment Group) statement on the evolving COVID-19 pandemic
The Position of Correlation-European Harm Reduction Network and EHRA on the Continuity of Harm Reduction Services During the COVID-19 Crisis
Human Rights Dimensions of COVID-19 Response
COVID-19: Sex Workers Need Immediate Financial Support and Protection
COVID19: “Staying Home” Not an Option for People Experiencing Homelessness
Coronavirus: Healthcare and human rights of people in prison

View FAQs about COVID-19 and people living with HIV

View FAQs

If you have questions or comments about HIV and COVID-19, let us know [email protected]